Aclaris Therapeutics, Inc. Gains 46.18%
Tue, Nov 19, 2024 at 07:33 PM
Aclaris Therapeutics, Inc. (ACRS:NASDAQ) soared at $4.59, representing a gain of 46.2%. On Tue, Nov 19, 2024, ACRS:NASDAQ hit a New 2-Week High of $4.59. The stock got featured on our News Catalysts scanner on Tue, Nov 19, 2024 at 05:39 PM in the 'MISCELLANEOUS' category. From Tue, Nov 05, 2024, the stock recorded 50.00% Up Days and 63.64% Green Days
About Aclaris Therapeutics, Inc. (ACRS:NASDAQ)
Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.
Top 10 Gainers:
- PainReform Ltd. (PRFX:NASDAQ), 161.68%
- Volato Group Inc. Class A (SOAR:NYSEMKT), 122.7%
- noco-noco Inc. (NCNC:NASDAQ), 67.01%
- Next Technology Holding Inc. (NXTT:NASDAQ), 61.76%
- Interactive Strength Inc. (TRNR:NASDAQ), 55.73%
- Aclaris Therapeutics, Inc. (ACRS:NASDAQ), 46.18%
- Dogwood Therapeutics Inc. (DWTX:NASDAQ), 40.54%
- Syros Pharmaceuticals, Inc. (SYRS:NASDAQ), 39.24%
- S&W Seed Company (SANW:NASDAQ), 34.36%
- Telomir Pharmaceuticals Inc. (TELO:NASDAQ), 34.14%